Clinical Trial Update: Ph3 Study To Determine Safety,Tolerability&Tumor Response Of Oraxol Compared To Taxol In Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing Oraxol to Taxol in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Oraxol
• Taxol (paclitaxel)

Snippet

Sponsor: Athenex, Inc. | Conditions: Metastatic Breast Cancer | Phase 3 | Status: COMPLETED